Disable ads (and more) with a membership for a one time $4.99 payment
What key identifier must be included on repackaged drugs?
Patient ID
Manufacturer name
Pharmacy's lot number
Prescribing doctor's license number
The correct answer is: Pharmacy's lot number
Including the pharmacy's lot number on repackaged drugs is essential for several important reasons. The lot number serves as a unique identifier that helps track the drug throughout its lifecycle, from repackaging to dispensing. This is particularly crucial in the event of a recall or investigation, as it allows pharmacies to quickly identify and locate affected products to ensure patient safety effectively. The lot number also aids in maintaining inventory control and ensures that the pharmacy can manage its stock efficiently, tracking expiration dates and the handling of medications. This practice is a standard regulatory requirement to enhance accountability in medication distribution and to ensure quality assurance measures are in place. While including other identifiers, such as the manufacturer name, is also important for ensuring transparency and patient safety, they do not provide the same level of traceability as the pharmacy's lot number does in the context of repackaged drugs. Patient ID and prescribing doctor's license numbers are more related to individual prescriptions rather than the repackaging process itself.